Browse by Email

Article

Paterson, D. L. and Sulaiman, H. and Po-Yu, L. and Chatfield, M. and Yilmaz, M. and Salmuna, Z. N. and Mazlan, M. Z. and Anunnatsiri, S. and Sirijatuphat, R. and Chotiprasitsakul, D. and Lye, D. and Somani, J. and Kalimuddin, S. and Thamlikitkul, V. and Lee, Y. T. and Lin, Y. T. and Yang, Y. S. and Wan Ramli, Wan Nurliyana and Ong, H. C. and Mootsikapun, P. and Meesing, A. and Tseng, C. H. and Yeh, T. K. and Hashim, A. M. B. and Puangpatra, P. and Aslan, A. T. and Santanirand, P. and Chiang, T. T. and Archuleta, S. and Chan, Y. F. Z. and Chia, P. Y. and Sahin, M. and Yigitbasi, A. A. and Forde, B. and Wright, H. and Stewart, A. and Ling, W. P. and Rossi, V. and Harris-Brown, T. and Harris, P. N. A. (2024) Investigator-driven randomised controlled trial of cefiderocol vs standard therapy for healthcare associated and hospital acquired Gram-negative bloodstream infection (GAMECHANGER). CMI Communications, 1 (Suppl. 1). p. 4751. E-ISSN 2950-5909